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Abstract
Background and Objectives: The dairy industry is in constant search for newer milk clotting coagulants to substitute rennet due to its
growing demands and controversies such as; its origin from young slaughtered animals. Kistomin (EC:3.4.24) is a protease long identified
on its role to cleave platelet and fibrinogen. In this study, kistomin discovered to function as a milk coagulant and investigated for its milk
clotting activities. Materials and Methods: Kistomin investigated by measuring its Milk Clotting Activity (MCA) and Proteolytic Activity
(PA), optimum conditions of pH, temperature, concentrations of enzyme and calcium chloride, exposures to various chelating agents and
cofactor ions. Results: The MCA of kistomin was 810.44 (SU mLG1) and the PA was 1.39 (U mLG1), resulted in a ratio of MCA/PA value of
583. The coagulating activity of kistomin on milk was the highest at 0.76 mg mLG1 enzyme concentration, 8% (w/v) of CaCl2 concentration,
the temperature of 48EC and stable over a wide range of pH 5-7 with activity peaking at pH6.5. The protease completely inhibited by EDTA
and 1,10 phenanthroline verifying to be a metalloprotease. The addition of Ba2+, Mn2+ and Ca2+ significantly increased the enzyme activity
but inhibited by Hg2+, Pb2+ and Fe2+ ions. Kistomin promoted extensive hydrolysis of κ-casein and low level of β-casein cleavage.
Conclusion: This concluded that kistomin can be used as a milk clotting candidate for the dairy industry.
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INTRODUCTION
Milk is made up of 3-4% total protein with approximately
80% of milk protein is casein and will coagulate or clot at
isoelectric pH of casein at pH4.6 or driven by protease
hydrolysis to form curd (gel-like) and whey (liquid)1. Since, the
milk coagulation properties significantly affect the yield and
quality of dairy products such as cheese or yogurt, they are
getting more and more attention in recent years2. Enzyme milk
clotting can be generally divided into three steps: Activation
of milk clotting particles (casein micelles), aggregation of
enzyme-modified casein micelles and lastly is the modification
for the properties and structure of the coagulum3. During the
aggregation of casein micelles, the concentration of calcium
ions reduces the electrostatic resistance of micelles by
neutralizing the surface charge on casein micelles, hence
promoting the casein micelles aggregation4.
The rennet obtained from calf contains more than 90% of
chymosin which is responsible for the milk coagulation of milk
to curd in the dairy products industry5. Chymosin is a protease
secreted in the stomach of young ruminants like calves and
kids raising ethical awareness in the slaughtering of such
young animals. The advanced technology of recombinant
DNA permits the cloning of chymosin using microorganisms3.
Additionally, genetic engineering can be employed to
enhance protein stability and modulate the activity6.
Genetically modified organism or living modified organism
experiencing their challenges suspected to cause allergic
reactions prompting Genetically Modified (GM) labeling of
such products. In the last decade, there has been an increased
demand for cheese consumption and production due to the
population explosion7. With the increased demands of rennet
enzymes, restricted use of animal rennet for certain religions
(e.g., porcine rennet for Islam), diets (vegetarianism), safety
(bovine spongiform encephalopathy) and activist against
genetically engineered foods, other possible alternative
sources of rennet are studied and exploited8. Kistomin being
a homogenous protease allows the opportunity to be studied
on its ability to coagulate milk and as an alternative source for
rennet.
The final stage of blood coagulation is the conversion of
the soluble fibrinogen to the insoluble fibrin-clot9. This
conversion occurs by the hydrolysis of the protease thrombin
of fibrinogen molecule10. Meanwhile, for milk clotting, it was
stated that 9-casein (casein fraction which acts as the
substrate of chymosin) is the main protagonist in the primary
phase of milk coagulation. According to Rutherfurd and Gill11,
there are similarities of sequence between fibrinogen γ-chain
and  9-casein.   The  clotting  of  the  blood  and  milk  process
possesses a common feature on the action of thrombin on
fibrinogen and the action of chymosin on 9-casein. It was
suggested that they are having a similar mechanism for these
enzymatic cleavages. Both processes are said to involve
limited proteolysis where both use protease enzymes to
hydrolyze specific linkages11. Kistomin cleaves alpha- and
gamma-chains of fibrinogen leaving the beta-chain
unaffected12. It is one of the metalloproteinases extracted from
Calloselasma rhodostoma venom. A metalloproteinase is a
protease enzyme where the water molecule that is used for
hydrolysis is complexed to a metal ion in the catalytic center
of the enzyme and the metal ions itself hold in the position by
several amino acid residues13. Kistomin is a 47446 Da
molecular weight monomer of 417 amino acids with zinc
bound at positions of 333, 337 and 34312,14. Kistomin being a
protease needs to be explored as well for its potential in milk
clotting. In this study, Kistomin is known to cleave specific
blood protein hence rationalized able to also cleave protein
specifically casein in milk. Kistomin was investigated for its
important features to coagulate milk to become curd and
whey.
MATERIALS AND METHODS
Study area: This study conducted between Sept, 2017 and
Aug, 2019.
Isolation of kistomin using stepwise chromatography
techniques: The purification of kistomin to homogeneity done
as previously described in Vejayan et al.15. Briefly, freeze-dried
C. rhodostoma venom (purchased from Snake and Reptile
Farm, Sungai Batu Pahat, Perlis, Malaysia) fractionated to its
active peak using a HiTrap SP FF (GE Healthcare Life Sciences)
pre-packed with Sulfopropyl Sepharose Fast Flow, a strong
cation connected to the ÄKTAexplorer (Amersham
Biosciences,  Sweden).  A   50   mM   ammonium   acetate  at
pH 6.0 and 1.0 M NaCl in 50 mM ammonium acetate at pH 6.0
were the start buffer and elution buffer, respectively. The
active fraction from the ion exchange chromatography
collected, freeze-dried and consequently desalted by using
HiTrap Desalting (GE Healthcare Life Sciences, USA), a
prepacked Sephadex G-25 Superfine column. Next, the active
fraction eluted from the ion exchange chromatography
column was applied  onto  HiPrep  26/60  Sephacryl  S  200  HR
pre-packed column (GE Healthcare Life Sciences, USA). The
column was equilibrated with 50 mM of ammonium acetate
buffer of pH 7 and the elution was carried out using the same
buffer with 2 mL sample injection at a flow rate of 1  mL  minG1
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to yield kistomin known peak (denoted as peak 5b)15. The
protein   content   of  the  kistomin  estimated by using the
dye-binding technique of Bradford16 with Bovine Serum
Albumin (BSA) at 2.0 mg mLG1 concentration, purchased from
Thermo Fisher Scientific, USA.
Milk Clotting Activity (MCA): The milk clotting activity of the
kistomin determined by using the method of Arima et al.17 and
Majumder et al.18 with few modifications. A 10% (w/v) of BD
Difco  skim  milk  (Thermo  Fisher  Scientific, USA) containing
10 mM of CaCl2 as a substrate. A total of 1 mL of milk substrate
was added to the 0.5 mL enzyme solution at 35EC. The milk
clotting time was measured according to 3 visible parameters,
i.e., viscosity, color changes and the development of white
spots19,20. Milk clotting activity was expressed in Soxhlet Unit
(SU mLG1). One SU was defined as the enzyme amount which
clots 1 mL of the substrate within 40 min at 35EC. The MCA for
coagulant was calculated by using the equation:





M = Volume of substrate (mL)
t = Clotting time (s)
E = Volume of enzyme (mL)
T = Reaction temperature (EC)
Proteolytic Activity (PA): The proteolytic activity was
measured by using 2.5 mL of 1% (w/v) casein (Nacalai Tesque,
Japan) in 50 mM potassium phosphate buffer (pH 7.5). The
casein solution was equilibrated in a water bath  at  37EC  for
10 min. A total of 0.1 mL kistomin and a blank (without any
coagulant) added to the casein preparations and incubated at
35EC for 30 min. After incubation, 2.5 mL of 440 mM
trichloroacetic acid (Sigma Aldrich, USA) was added to stop
the reaction. Then the appropriate volume of enzyme solution
was added, also in the blank so that the final volume of
enzyme solution in each is 1 mL. The solution was incubated
again at 35EC for 30 min and was centrifuged at  12000 g for
10 min. A total of 5  mL  of  500  mM  sodium  carbonate
(Sigma Aldrich, USA) was added to 2 mL supernatant and 1 mL
of Folin and Ciocalteu’s phenol reagent (Sigma Aldrich, USA)
was added immediately afterward. The absorbance of the
solution was measured at 660 nm.
The standard calibration curve of L-tyrosine (Sigma Aldrich,
USA) was prepared between range 0.0-0.60 µMoles. In  each
2 mL  concentration  of  tyrosine,  a  total  of  5  mL  of 500  mM
sodium carbonate and 1 mL of Folin reagent added
immediately. The absorbance of the solution was measured at
660 nm by using a UV-V is spectrophotometer.
The calibration curve of L-tyrosine concentration (µMoles)
versus Absorbance (660 nm) was constructed and the
equation was generated using MS Excel software. The enzyme
activity for kistomin calculated by using this equation19:
Tyrosine equivalent released ( Moles)
units Totalin assay(mL)Activity ( ) Timeof assay (min) protease (mL)mL




Determining optimum parameters of kistomin coagulant:
A total of 1 mL of 10% (w/v) skim milk (BD Difco, Thermo
Fisher Scientific, USA) containing 10 mM CaCl2 (Sigma Aldrich,
USA) was used as the milk substrate (except during the
determination of optimum CaCl2 concentration). The
temperature and pH maintained to be constant at 35EC and
pH 6.5 (except during the determination of optimum
temperature and pH).
Enzyme concentration: Kistomin was serially diluted in the
range of 0.01-1.28 mg mLG1 protein content. A total of 1 mL of
milk substrate was then introduced to 0.5 mL of different
concentrations of the coagulant at 35EC, pH 6.5. The time
taken for the milk to coagulate was recorded based on three
visible parameters, i.e., viscosity, color changes and the
development of white spots19,20. The protein concentration
was increased until the coagulation rate become constant and
the graph of MCA versus concentration was plotted. 
pH: The pH stability of kistomin investigated at pH 5-9. Acetate
buffer (pH 5), phosphate buffer (pH 6-pH 8) and glycine-NaOH
buffer (pH 9) used. Each 0.5 mL of sample solution consisting
of coagulant and  an  appropriate  buffer  with  varying pH of
5- pH 9 was mixed with 1 mL of milk substrate and swirled for
10 sec at 35EC. The time taken for the milk to coagulate was
recorded. The graph of MCA versus pH was plotted. 
Temperature: The milk substrate (pH 6.5) with kistomin was
incubated in a water bath with varying temperature settings
i.e., 20-80EC. The time taken for the milk to coagulate was
recorded. The graph of MCA versus temperature (EC) was
plotted.
Calcium ion concentration: Various concentrations of CaCl2
ranging from 2-14% (w/v) dissolved in 1 mL of 10% (w/v) skim
milk at 35EC and pH 6.5.  A volume of 0.5 mL  of the  coagulant
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was mixed with the skim milk and swirled for 10 sec. The time
taken for the milk to coagulate was recorded. The graph of
MCA vs. CaCl2 concentration (w/v) was plotted.
Substrate specificity of kistomin: Substrate specificity of
coagulant was determined by using  a  substrate  range of
0.05-5.0   mg   mLG1   for   κ-casein    and    $-casein    while
0.05-8.0 mg mLG1 of "-casein (all purchased from Sigma
Aldrich, USA). The substrates were dissolved in 50 mM
potassium phosphate buffer (pH 6.5) and were serially diluted.
The reaction was initiated by adding 100 µL (0.015 mg) of
kistomin and was incubated for 10 min at 48EC. 
The reaction stopped by adding 900 µL of trichloroacetic
acid (TCA) and the solution was incubated for 30 min. After
incubation,   the   solution   was  centrifuged  at  12000 g  for
10 min. One milliliter of supernatant was mixed with 900 µL of
500 mM sodium carbonate and 100 µL of Folin reagent. The
absorbance of the solution was measured at 660 nm. The
substrate specificity of kistomin toward substrates was
compared by using the Km value calculated by the Michaelis
Menten equation with nonlinear regression by using
GraphPad Prism 7 software.
Effects of protease inhibitor and metal ions on kistomin
activity: All materials for this experiment sourced from Sigma
Aldrich, USA. The effects of various metal ions and protease
inhibitors were determined by using 2% (w/v) of casein
dissolved in 50 mM potassium phosphate buffer (pH 6.5) as a
substrate. A total of 100 µL of 20 mM of various metal ions
(CuSO4, MgCl2, MgSO4, FeSO4, Pb (NO3)2, HgCl2, BaCl2, MnSO4
and CaCl2) and protease inhibitor: 10 mM PMSF, 1 mM
Pepstatin A, 10 mM EDTA, 5 mM Iodoacetamide and 10 mM
1,10  phenanthroline   was   pre-incubated   with   100 µL
(0.015 mg) protease for 10 min in 48EC. One milliliter of the
substrate was then added to each tube containing the mixture
of the enzyme and metal ions/inhibitor.
The  solution  was  incubated in the water bath for 30 min
at 48EC and  the  reaction  was  stopped  by  adding   900   µL
of trichloroacetic acid  (TCA).   The  solution  was  incubated 
for   10  min.  After  incubation,  the  solution was centrifuged
at 12000 g  for  10  min.  One milliliter of supernatant was
mixed with 900 µL of 500 mM sodium carbonate and 100 µL
of Folin reagent. The absorbance of the  solution  was 
measured  at 660 nm. The residual activities were determined
and compared to the control which prepared by
preincubating the enzyme with buffer and corresponds to
100% activity.
RESULTS AND DISCUSSION
The values determined for MCA, PA and ratio of MCA/PA of
kistomin were 810.44±42.45 SU mLG1, 1.39±0.01 U mLG1 and
583.05, respectively. In general term Milk Coagulating Activity
(MCA) is the ability of the rennet to aggregate milk by cleaving
the amino acid of Phe105-Met106 of 6-casein21. The high value of
MCA indicating that the enzyme has good potential as a
coagulant in the dairy industry. The second property is
Proteolytic Activity (PA) which is the ability of the coagulant to
cleave any bond of casein22.  A high value of Milk Clotting
Activity/Proteolytic Activity (MCA/PA) reflects an excellent end
product of cheese with desirable firmness with no bitter
flavors. The high ratio of MCA/PA is considered a good
coagulant so the higher the value, the better the coagulant
and its generally indicates the restricted degradation of casein
substrate23-25. The major drawback of the protease extracted
from most plant sources has the excessive proteolytic nature
and low MCA/PA ratios which limited their use in cheese
manufacturing such as ginger, curcumin or hieronyma in
protease26,27. The measured value of 583 for kistomin found
higher than 367 for papain. Papain has been suggested not
useful as a coagulant due to the bitterness of the curd
obtained28. Although the MCA/PA ratio calculated for kistomin
better than papain nevertheless not possible to ascertain
whether this MCA/PA ratio obtained is suitable as a dairy
industry protease as there is no sufficient data available on the
lower cut-off value for the ratio. 
As shown in Fig. 1 the several factors affecting the
enzymatic reaction of kistomin in milk clotting. The profiles of
the graphs were as expected of an enzyme reacting on a
substrate. Initially, to determine the optimum enzyme
concentration the temperature and pH maintained constant
to 35EC and pH7, respectively while CaCl2  given  more  than
10 mM. The clotting activity was expressed in Soxhlet Unit
(SU). One Soxhlet Unit (SU) of milk clotting activity was defined
as29 the amount of enzyme required to coagulate 1 mL of the
substrate within 40 min at 35EC. The clotting activity increase
when enzyme concentration increased because of a higher
level of proteolysis of kappa casein19. The optimum
concentration of 0.76 mg mLG1 determined based on Fig. 1a as
the highest milk clotting activity achieved by kistomin.
Consequently, all other optimum conditions for kistomin with
the highest milk clotting activity determined to be 48EC for
temperature (Fig. 1b), pH 6.5 (Fig. 1c) and CaCl2 concentration
of 8% w/v (Fig. 1d).
Figure 2a,b showed the milk clotting time of kistomin
under optimum conditions for temperature, pH as well as
concentrations   of   enzyme   and   CaCl2.   The  images  viewed
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Fig. 1(a-d): Graph of (a) Milk clotting activities versus enzyme concentration, (b) Temperature, (c) pH, (d) CaCl2 concentration
Values are the Mean±Standard Deviation, n = 4
Fig. 2(a-b): Coagulating activity of kistomin on milk at optimum parameters (a) Before Coagulation (b) After coagulation
The coagulation time determined (n = 4) at optimum conditions of kistomin: Enzyme concentration of 0.76 mg mLG1, 48EC for temperature, pH 6.5 and
CaCl2 concentration of 8% (w/v). Observation under light microscope at low magnification (100X) of; (a) Control, bovine skim milk and (b) Coagulated
by kistomin
under microscopic magnification clearly showed the
formation  of  gaps represented by whey after milk
coagulated.  The observation before coagulation showed milk
without any aggregation of casein micelles however
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The optimum temperature30 for metalloproteinase
enzyme stated between 37-55EC. The optimum temperature
for kistomin reduced the risk of contamination by mesophilic
microorganisms that able to grow at a moderate temperature
between 20-45EC and with optimum growth temperature
between 30-39EC. The elevation of temperature additionally
favors substrate and product solubility, increases reaction
rates for reducing viscosity and for increasing the diffusion
coefficients of substrates31. Higher than room temperature is
favored for the milk coagulant in the dairy industry. The
commercial calf rennet shows the optimum temperature
between 39-45.5EC15,19,32. Genetically engineered calf
chymosin for cheese production found with an optimum
temperature of 45EC33. This shows that kistomin has potential
as a coagulant in the cheese industry as it has a broad range
of thermal stability and has a high optimum temperature.
Additionally, if required in the future, a recombinant kistomin
variant can be generated to lower the optimum temperature
in reducing the cost of cheese production.
The kistomin is shown to be favorable in the acidic
environment as it stable at pH 5 to pH 6.9 with an optimum pH
at 6.5. The amino acid sequence of kistomin was computed by
using ProtParam tool-ExPASy online software and the results
showed that the total number of negatively charged residues
(Aspartic acid and Glutamic acid) is higher than the total
number of positively charged residues (Arginine and Lysine)34.
This protein also moderately stable at pH 7 which maintained
71% of its activity. In comparison to the chymosin (industrial
rennet) found to cleave κ-casein of milk at the optimum pH
between 5.1-5.535. In industry additional cost required to be
considered to adjust pH to be highly acidic or basic.
The addition of calcium chloride was reported to affect
the milk coagulation as it reduces the milk coagulation time36.
Calcium chloride speeds up the milk coagulation as calcium
ions reduced the electrostatic resistance of micelles by
neutralizing the surface charge on casein micelles4. The
calcium ions also form bridges between micelles of para
casein indicating that the more there are calcium ions in milk,
the more there will be linkage19. This promotes the
aggregation of casein micelles and leads to faster milk
coagulation. However, the addition of calcium chloride
beyond what is required leads to the rate of milk clotting
activity to gradually decrease. This is due to the high
concentration of calcium chloride, Ca2+ ions present inhibits
the milk clotting network19. It is therefore necessary in
providing the optimum or even slightly lower concentration
of CaCl2 rather than resorting to excess for milk clotting
activity. 
Table 1: Kistomin specificity toward various casein substrates




Values are the Mean±Standard deviation, n = 4
Table 2: Effect of different protease inhibitors on the activity of kistomin
Protease inhibitor Activity (%)±SD
Control (no inhibitor) 100
PMSF (serine inhibitor) 64.99±2.77
EDTA (metalloproteinase inhibitor) 0
Iodoacetamide (cysteine protease inhibitor) 81.43±3.48
Pepstatin A (aspartic protease inhibitor) 88.58±6.39
1, 10-phenanthroline (metalloproteinase inhibitor) 0 
Values are the Mean±Standard Deviation, n = 4
Table 1 compared the Vmax and the Km of α-casein, $-casein
and  κ-casein  by  kistomin.  The results   showed   the   Vmax
and  Km  value  of  kappa-casein  is  the   lowest,
0.0275±0.0019 µmoL minG1 and 27.15±5.277 mM,
respectively. This indicated kistomin has a high affinity
towards kappa casein and potentially preferred cleaving it to
curd and whey fastest. The major enzyme of calf rennet,
chymosin has been extensively used in the production of
cheese to produce a stable curd with good flavor due to its
high specificity for κ-casein37. The specificity of kistomin for
casein was  similar  to  chymosin  which  extensively  cleaved
κ-casein and promoted very slight hydrolysis of β-casein. The
specificity of kistomin on κ-casein followed by α-casein. This
can avoid the bitterness development of cheese which is
considered as a defect in cheese. It has been reported that the
hydrolysis of casein especially β-casein generates hydrophobic
peptides which when accumulating is responsible for the
bitterness  of  dairy products. The higher the affinity towards
$-casein leads to the product of hydrophobic peptides hence
becoming bitter cheese38. In this instance, it was found
kistomin having a lower affinity towards β-casein based on
higher Km.
Table 2 showed the effect of protease inhibitors on
kistomin. Kistomin was incubated with five different protease
inhibitor and the residual activities of the protease were
determined and compared with the control which
corresponds to 100% of activity. Kistomin was completely
inhibited in the presence of EDTA and 1,10-phenanthroline
and the maintenance of activity in the presence of
iodoacetamide (cysteine protease inhibitor), pepstatin A
(aspartic protease inhibitor)   and   PMSF   (serine  inhibitor) 
inhibitors. Kistomin is  a  metalloprotease  and  as  expected  
both   EDTA  and 1,10-phenanthroline inhibited it similar to
previous observations14,39. EDTA and 1, 10-phenanthroline 
inhibit metalloprotease activity by lowering the concentration
of metal ion and removed it from the active site of the
enzyme40.
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Fig. 3: Effects of various metal ions on milk clotting activity of
kistomin
Values are the Mean±Standard Deviation, n = 4
Figure 3 showed the effects of metal ions on milk clotting
activity of the kistomin enzyme. The addition of Mn2+, Ba2+ and
Ca2+ (in descending orders) significantly increased the enzyme
activity. However, kistomin was inhibited by Hg2+, Pb2+ and
Fe2+ ions. The effect of ions over protease stability because of
interaction between them, with the formation of complexes
such as ions used as cofactors, substrates and co-substrates31.
Kistomin is a metalloprotease enzyme and this class of
proteases is characterized by its requirement of divalent metal
ions for its catalytic activity37. Metalloprotease usually
associated with Zn2+, but other metals have been found at the
active site of metalloproteases41-43, such as; Mn2+, Ca2+, Mg2+,
Cu2+ and Co2+. Pb2+ and Hg2+ were found to be toxic when
present in high amount. A similar result was found where the
metalloprotease isolated from Oudemansiella radicata was
inhibited44 by Hg2+, Pb2+ and Fe2+. Also, Hg2+ also has been
reported to inhibit keratinolytic metalloprotease from
Microbacterium sp.45.
CONCLUSION
Kistomin is shown as a capable milk coagulant with
MCA/PA ratio better than papain and having optimum
conditions of 0.76 mg mLG1 enzyme concentration, 48EC
temperature,  pH6.5  and  8%   CaCl2   concentration.   Its
affinity  at  least  towards  β-casein likely producing cheese
with  less  bitter  taste.  Kistomin  completely  inhibited by
EDTA and 1,10 phenanthroline verifying it as a
metalloproteinase and required most the metal ion of Mn2+ as
a cofactor.
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SIGNIFICANCE STATEMENT
This study discovered the kistomin function of
coagulating milk to curd and whey. The study determined and
revealed the protease MCA/PA ratio, rapid coagulation time,
specificity towards kappa casein rather than beta-casein, its
preferred cofactor and optimum conditions. Overall this work
introduces a potential protease in its natural and homogenous
state capable to coagulate milk to curd with important
features highlighted. Its potential capabilities can be improved
further by other researchers by genetic engineering to
become an alternative coagulant to chymosin.
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